FibroGen

AstraZeneca, FibroGen hope to keep their roxadustat dream alive with new FDA meeting
Fierce Pharma
Wed, 11/10/21 - 10:42 am
FibroGen
AstraZeneca
anemia
roxadustat
FDA
GSK pulls off clean sweep of endpoint hits in anemia phase 3, positioning it to leapfrog AstraZeneca
Fierce Biotech
Mon, 11/8/21 - 10:47 am
GSK
chronic kidney disease
cliincal trials
FDA
AstraZeneca
anemia
erythropoietin
FibroGen
FibroGen, fresh off data manipulation scandal, touts win in cancer patients without revealing data
Endpoints
Wed, 08/25/21 - 11:20 am
FibroGen
roxadustat
cancer
anemia
clinical trials
data manipulation
After FDA snub, EMA backs FibroGen, Astellas’ roxadustat
Pharmaforum
Fri, 08/20/21 - 10:51 am
Europe
FibroGen
Astellas
Evrenzo
anemia
chronic kidney disease
FDA declines to approve FibroGen's anemia drug
Yahoo/Reuters
Wed, 08/11/21 - 12:07 pm
FibroGen
FDA
anemia
chronic kidney disease
roxadustat
FibroGen slides after FDA posted documents ahead of AdCom meeting on Roxadustat
Seeking Alpha
Tue, 07/13/21 - 11:06 am
FibroGen
FDA
roxadustat
advisory panels
chronic kidney disease
FibroGen shares take a beating as CEO reveals safety data manipulation for its blockbuster contender roxadustat
Endpoints
Tue, 04/6/21 - 11:13 pm
FibroGen
anemia
roxadustat
FibroGen shares skid lower as a surprise adcomm raises risks on roxa OK
Endpoints
Tue, 03/2/21 - 10:59 am
FibroGen
roxadustat
FDA
advisory panel
Aducanumab tops 2021’s biggest potential launches
EP Vantage
Mon, 01/18/21 - 01:04 pm
drug launches
Biogen
Eisai
aducanumab
efgartigimod
Argenx
Evrenzo
FibroGen
Astellas
AstraZeneca
Leqvio
Novartis
UCB Pharma
bimekizumab
Ascendis Pharma
Bluebird Bio
Bristol-Myers Squibb
ide-cel
liso-cel
AXS-05
Axsome Therapeutics
voclosporin
Aurinia
AstraZeneca, FibroGen's roxadustat hits snag at FDA, but analysts figure an approval's still on its way
Fierce Pharma
Mon, 12/21/20 - 11:46 pm
AstraZeneca
FibroGen
roxadustat
FDA
anemia
Astellas, FibroGen get approval in Japan for Evrenzo to treat anaemia of CKD in adult patients not on dialysis
Pharmaceutical Business Review
Sun, 11/29/20 - 02:10 pm
Astellas
FibroGen
Japan
Evrenzo
chronic kidney disease
FibroGen Provides More Support for Roxadustat in Anemia Associated with Kidney Disease
BioSpace
Mon, 10/26/20 - 11:15 pm
FibroGen
roxadustat
ASN
chronic kidney disease
5 FDA approval decisions to watch in the 4th quarter
BioPharma Dive
Wed, 09/30/20 - 10:45 am
FDA
drug approvals
vaccines
Pfizer
Moderna Therapeutics
COVID-19
Regeneron
EB3
ebola virus
Alkermes
ALKS-3831
schizophrenia
bipolar disorder
Bristol-Myers Squibb
liso-cel
non-Hodgkin lymphoma
roxadustat
FibroGen
chronic kidney disease
Easing concerns, FibroGen, AstraZeneca secure FDA date for their anemia drug in broad chronic kidney disease population
Endpoints
Wed, 02/12/20 - 10:50 am
FibroGen
AstraZeneca
FDA
anemia
chronic kidney disease
roxadustat
Data From 3 Roxadustat Trials Lead Off Kidney Week Sessions Ahead of Efficacy, Safety News
Managed Markets Network
Sat, 11/9/19 - 12:12 pm
nephrology
roxadustat
AstraZeneca
FibroGen
kidney disease
FibroGen founder Thomas Neff dies suddenly as drug he championed racks up milestones
Fierce Pharma
Mon, 08/26/19 - 12:32 pm
FibroGen
Thomas Neff
Pharma CEOs
roxadustat
AstraZeneca's Kidney Drug Roxadustat Gets Second Nod in China
Yahoo/Zacks.com
Fri, 08/23/19 - 10:04 am
AstraZeneca
FibroGen
China
roxadustat
chronic kidney disease
The Week Ahead In Biotech: Pending Clinical Readouts In Focus
Yahoo/Benzinga
Mon, 07/1/19 - 10:32 am
Retrophin
Karyopharm
Celyad
uniQure
Sangamo Therapeutics
Catalyst Biosciences
Novo Nordisk
Reata Pharmaceuticals
Vertex Pharmaceuticals
Bellicum
Gilead Sciences
Jaguar Health
TRACON Pharmaceuticals
FibroGen
Aslan Pharma
ObsEva
Sorrento Therapeutics
Roxadustat safety analysis provokes more questions than answers
EP Vantage
Fri, 05/10/19 - 10:29 am
FibroGen
roxadustar
anemia
AstraZeneca
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs
Yahoo/Benzinga
Sun, 03/24/19 - 12:02 pm
FDA
Novartis
Ascendis
Eiger BioPharmaceuticals
Proteostasis Therapeutics
Fibrocell Science
Supernus Pharmaceuticals
FibroGen
INSYS Therapeutics

Pages